폐경여성에서 Fas, Fas-ligand 유전자 다형성과 골밀도와의 연관성

키워드

참고문헌 (16)

1. "prophylaxis and treatment of osteoporosis", diag(sis), pp.646~50
2. "Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr", 21, pp.115~137 (2000)
3. "Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families", 38, pp.61~67 (1995)
4. "Role of genetic factors in the pathophysiology and management of osteoporosis", 54, pp.1~9 (2001)
5. "The mechanisms of estrogen regulation of bone resorption", 106, pp.1203~1204 (2000)
6. "Expression of Fas and NF-kappa B in the process of osteoclast like cell apoptosis effected by sodium fluoride", 24, pp.491~494 (2002)
7. "Osteoclast apoptosis:the role of Fas in vivo and in vitro", 144, pp.5545~5555 (2003)
8. "Apoptosis of osteoclast-like cells induced by alendronate is related to Fas gene expression", 3, pp.26~32 (2000)
9. "Tumor necrosis factor-alpha and interleukin-1 beta increase the Fas-mediated apoptosis of human osteoblasts", 134, pp.222~231 (1999)
10. "Genomic analysis of Fas and FaL genes and absence of correlation with disease progression in AIDS", 56, pp.56~60 (2004)
11. "Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome", 27, pp.2397~2405 (2000)
12. "Polymorphisms of Death Pathway Genes FAS and FASL in Esophageal Squamous-Cell Carcinoma", 96, pp.1030~1036 (2004)
13. "Genetic polymorphisms of Fas(CD95) and FasL(CD178) in human longevity: studies on centenarians", 23, pp.431~438 (2002)
14. "Estrogen treatment of patients with established postmenopausal osteoporosis", 76, pp.290~6 (1990)
15. "Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women", 82, pp.991~995 (1997)
16. "한국 폐경여성에서 비타민 D 수용체 유전자 다형성과 호르몬대체요법이 골밀도에 미치는 영향과의 연관성", 46, pp.984~990 (2003)

관련 논문AI추천